ArticleJournal of clinical medicine2024

Basiliximab vs. No Induction Therapy in Kidney Transplant Recipients with a Low Immunological Risk Profile Receiving Tacrolimus/Mycophenolate/Steroids Maintenance Immunosuppression.

Florian Lacave et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.